American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer (Q24607403)

From Wikidata

Jump to navigation Jump to search

scientific article in CA

Language	Label	Description	Also known as
English	American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer	scientific article in CA

Statements

scholarly article

0 references

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer (English)

0 references

0 references

Medical Biology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Nicolas Wentzensen

11

0 references

Eduardo L. Franco

object named as

Eduardo L Franco

15

0 references

17

object named as

Mark Schiffman

0 references

Philip E. Castle

18

object named as

Philip E Castle

0 references

2

object named as

Diane Solomon

0 references

author name string

Debbie Saslow

1

0 references

Herschel W Lawson

3

0 references

Maureen Killackey

4

0 references

Shalini L Kulasingam

5

0 references

Joanna Cain

6

0 references

Francisco A R Garcia

7

0 references

Ann T Moriarty

8

0 references

Alan G Waxman

9

0 references

David C Wilbur

10

0 references

Levi S Downs

12

0 references

Mark Spitzer

13

0 references

Anna-Barbara Moscicki

14

0 references

Mark H Stoler

16

0 references

Evan R Myers

19

0 references

language of work or name

0 references

publication date

2012

1 reference

0 references

62

0 references

3

0 references

147-72

0 references

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

What is "quality of evidence" and why is it important to clinicians?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Prevalence of HPV infection among females in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

7 April 2017

Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Comparative community outreach to increase cervical cancer screening in the Mississippi Delta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Special commentary: patient safety and the next generation of HPV DNA tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cervical cancer prevention: new tools and old barriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Economic evaluation of human papillomavirus vaccination in developed countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Trade-offs in cervical cancer prevention: balancing benefits and risks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Incorporating considerations of resources use into grading recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Going from evidence to recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

2006 consensus guidelines for the management of women with abnormal cervical screening tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Process of care failures in invasive cervical cancer: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Model for assessing human papillomavirus vaccination strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Chapter 2: The burden of HPV-related cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

HPV for cervical cancer screening: is the era of the molecular pap smear upon us?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Long term follow up of women after hysterectomy with a history of pre-invasive cancer of the cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

27 September 2017

Frequency of cervical smear abnormalities within 3 years of normal cytology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

30 May 2018

International incidence rates of invasive cervical cancer before cytological screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

30 May 2018

International incidence rates of invasive cervical cancer after introduction of cytological screening.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Screening for cervical cancer: will women accept less?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Screening interval and risk of invasive squamous cell cervical cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

The cost-effectiveness of male HPV vaccination in the United States.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cost-effectiveness of human papillomavirus vaccination and screening in Spain

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

New American Cancer Society process for creating trustworthy cancer screening guidelines.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Further analysis of the ARTISTIC trial

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21139

21 January 2018

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

28 November 2018

Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

28 November 2018

Interlaboratory reliability of Hybrid Capture 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

28 November 2018

A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3801360

28 November 2018

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding a Test for Human Papillomavirus DNA to Cervical-Cancer Screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Routine vaginal cuff smear testing in post-hysterectomy patients with benign uterine conditions: when is it indicated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACOG Practice Bulletin no. 109: Cervical cytology screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice improvement in cervical screening and management: symposium on management of cervical abnormalities in adolescents and young women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of genital human papillomavirus detection in a US population

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gynecological care of elderly women. Another look at Papanicolaou smear testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytologic screening after hysterectomy for benign disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/22422631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24607403&oldid=2043812199"